Skip to content

Dova Pharmaceuticals Inc.: filings

Every Dova Pharmaceuticals Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 10 filings, each linked to its SEC index.

Filing record ends 2019-11-12

The latest filing in this captured record is a 10-Q filed 2019-11-12. No later filing is in the SEC companyfacts record captured on 2026-09-22. Dova Pharmaceuticals Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-11-12fiscal Q3 2019401070001685071-19-000029
10-Q2019-08-06fiscal Q2 2019411050001685071-19-000023
10-Q2019-05-07fiscal Q1 201940820001685071-19-000015
10-K2019-03-05fiscal FY 2018381380001685071-19-000008
10-Q2018-11-08fiscal Q3 201837920001685071-18-000010
10-Q2018-08-09fiscal Q2 201838850001104659-18-050953
10-Q2018-05-09fiscal Q1 201830570001104659-18-031729
10-K2018-02-16fiscal FY 2017301070001104659-18-010386
10-Q2017-11-09fiscal Q3 201729680001104659-17-067405
10-Q2017-08-14fiscal Q2 201728630001104659-17-051546

Inspect the source

Entity
Dova Pharmaceuticals Inc. / CIK 0001685071
Captured
SEC response SHA-256
c8326c3a68fd35fbca4a66700b43251c5aaf34854e196cda6e4b0397c6f99b11

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001685071.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))